MPD: Phenotype measures mapped to VT:0002620, monocyte morphology trait

Phenotype measures associated with ontology term
VT:0002620 'monocyte morphology trait'

Navigate ontologies

All measures in this list are mapped to the ontology descendants of VT:0002620. None are mapped to VT:0002620 directly.

VT:0000223 monocyte quantity

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
CGDpheno1:7	CGDpheno1	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] pctMONO 31807	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno3:9	CGDpheno3	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] pctMONO 43909	CC diallel w/par	62	both	7wks	N=5	2012

Chesler2:14	Chesler2	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 43416	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:15	Chesler2	complete blood count	(none)	monocyte differential (MONO; percentage of viable WBC) [%] pct_MONO 43417	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler3:16	Chesler3	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 43516	CC pre w/par	198	both	7-15wks	N=1	2011

Chesler3:17	Chesler3	complete blood count	(none)	monocyte differential (MONO; percentage of viable WBC) [%] pct_MONO 43517	CC pre w/par	198	both	7-15wks	N=1	2011

Collins1:7	Collins1	complete blood count	(none)	monocyte count (MONO; per volume x 10³) [n/µL] MONO 45107	CC pre w/par	138	m	10-14wks	N=1	2012

Collins1:8	Collins1	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] MONO_pct 45108	CC pre w/par	138	m	10-14wks	N=1	2012

Donahue5:3	Donahue5	immune cell quantification	(none)	monocyte differential (percentage of viable WBC) [%] pct_MONO 41403	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue5:4	Donahue5	immune cell quantification	(none)	inflammatory monocytes (percentage of viable WBC) [%] pct_MONO_inflam 41404	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue5:5	Donahue5	immune cell quantification	(none)	resident monocytes (percentage of viable WBC) [%] pct_MONO_resident 41405	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue6:3	Donahue6	immune cell quantification	(none)	monocyte differential (percentage of viable WBC) [%] pct_MONO 41503	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:4	Donahue6	immune cell quantification	(none)	inflammatory monocytes (percentage of viable WBC) [%] pct_MONO_inflam 41504	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:5	Donahue6	immune cell quantification	(none)	resident monocytes (percentage of viable WBC) [%] pct_MONO_resident 41505	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Eumorphia1:27	Eumorphia1	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 23927	inbred	4	both	12wks	N=15	2007

HMDPpheno5:19	HMDPpheno5	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 48919	HMDP w/par	79	m	16wks	N=3	2013

HMDPpheno5:25	HMDPpheno5	complete blood count	(none)	monocyte differential (MONO; percentage of viable WBC) [%] pct_MONO 48925	HMDP w/par	79	m	16wks	N=3	2013

JaxCC1:9213	JaxCC1	complete blood count	(none)	monocyte differential (percent of total WBC) [%] pct_MONO 89213	CC	18	both	17-19wks	N=6	2017

JaxKOMP-EAP:437	JaxKOMP-EAP	complete blood count	(none)	monocyte differential (percent of total WBC) [%] pct_MONO monocytes_mono 100295	KOMP	1833	both	18wks	N=7	2021

JaxKOMP-LAP:325	JaxKOMP-LAP	complete blood count	(none)	monocyte differential (percent of total WBC) [%] pct_MONO monocytes_mono 101295	KOMP	102	both	75-81wks	N=6	2021

Jaxpheno4:14	Jaxpheno4	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 22914 age 8wks age 16wks	inbred	11	both		N=17	2006

Jaxpheno4:34	Jaxpheno4	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] pct_MONO 22934 age 8wks age 16wks	inbred	11	both		N=17	2006

Jaxpheno6:22	Jaxpheno6	immune cell quantification	(none)	splenic monocytes (percentage of total viable cells) [%] pct_Mono 23122 8wks 16wks	inbred	11	both		N=9	2006

Justice2:16	Justice2	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] pctM 13216	inbred	16	both	12-16wks	N=12	2002

Lake1:5	Lake1	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] pct_MONO 19905	B6.A consomic w/par	23	both	7wks	N=8	2005

Lake1:82	Lake1	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 19982	B6.A consomic w/par	23	both	7wks	N=8	2005

Peters1:13	Peters1	complete blood count	(none)	monocyte differential (percent of total WBC) [%] MONO 6213	inbred w/CC7	43	both	10wks	N=11	2001

Peters2:13	Peters2	complete blood count	(none)	monocyte differential (percent of total WBC) [%] MONO 6513	AXB BXA	28	both	11wks	N=8	2004

Peters4:17	Peters4	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 24317 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:41	Peters4	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] pctMONO 24341 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Petkova1:21	Petkova1	immune cell quantification	(none)	monocyte differential (MONO; percentage of total WBC) [%] MONO 24221 6mo 12mo 18mo 24mo	inbred	32	both		N=7	2007

Schughart4:61	Schughart4	complete blood count	influenza A (H3N2) virus	monocyte differential (percent of total WBC), control group, day 3 [%] pctMONO_ctrl_d3 58761	inbred w/CC8	8	f	8-12wks	N=5	2016

Schughart4:63	Schughart4	complete blood count	influenza A (H3N2) virus	monocyte differential (MONO; percentage of total WBC), treated group [%] pctMONO_trt 58763 days post-infection: 3 5 8 18 30	inbred w/CC8	8	f	8-12wks	N=6	2016

Svenson3:5	Svenson3	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] pctMONO 27305	B6.PWD consomic w/par	28	both	7wks	N=8	2006

Wiltshire4:13	Wiltshire4	immune cell quantification	BEZ235	monocytes, percent viability [%] monocytes_BEZ 52413 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:33	Wiltshire4	immune cell quantification	doxorubicin	monocytes, percent viability [%] monocytes_Dox 52433 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:53	Wiltshire4	immune cell quantification	idarubicin	monocytes, percent viability [%] monocytes_Ida 52453 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:73	Wiltshire4	immune cell quantification	selumetinib	monocytes, percent viability [%] monocytes_Sel 52473 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Filter Table Results